Biotechnology Company Regeneron to Buy 23andMe for $256 million
A look at why the publicly traded pharmaceutical giant is snapping the genetic-testing company out of bankruptcy.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
